glucagon like peptide 1 glp 1 Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease Classification of currently available glucagon-like

Over the past decade, GLP-1 therapies have largely relied on peptide-based injectable drugs

Nilesh Desai, a board-certified physician, with the team that already knows your health

In this class, we're seeing less of the big three heart outcomes, which is heart attack, stroke, and cardiovascular death

The presence of GLP-1 receptors in testicular tissue and evidence of direct, weight-loss-independent effects on sperm function raises the possibility that GLP-1 drugs may act on male reproductive biology through two distinct mechanisms simultaneously: one systemic (through metabolic improvement) and one local (through direct testicular signaling)

Beyond this window, patients should skip the dose and continue with the next scheduled injection

This kind of weight loss is significant and can be life-changing, especially for those who face obesity-related health problems